Amgen | AMGN - Gross Profit On Sales

Stock Price
279.08
Daily Change
-4.56 -1.61%
Monthly
-2.11%
Yearly
-14.35%
Q3 Forecast
281.29

Amgen reported $6.17B in Gross Profit on Sales for its fiscal quarter ending in June of 2025.




Gross Profit On Sales Change Date
AbbVie USD 9.34B 1.36B Mar/2025
Agios Pharmaceuticals USD 10.75M 3.11M Jun/2025
ALKERMES USD 257.77M 462K Jun/2025
Amgen USD 6.17B 624M Jun/2025
Biogen USD 2.04B 238.8M Jun/2025
BioMarin Pharmaceutical USD 670.47M 76.89M Jun/2025
Bristol-Myers Squibb USD 8.9B 714M Jun/2025
Eli Lilly USD 13.11B 2.61B Jun/2025
Exelixis USD 548.79M 12.52M Jun/2025
Genmab DKK 868M 195M Jun/2025
Gilead Sciences USD 5.58B 453M Jun/2025
GlaxoSmithKline GBP 5.82B 229M Jun/2025
Glaxosmithkline GBP 5.83B 232M Jun/2025
Incyte USD 1.14B 151.67M Jun/2025
Ionis Pharmaceuticals USD 448M 317.85M Jun/2025
J&J USD 14.6B 816M Mar/2025
Merck USD 12.99B 224M Jun/2025
Moderna USD 18M 1000K Jun/2025
Neurocrine Biosciences USD 676.2M 112.8M Jun/2025
Novartis USD 11.51B 1.12B Jun/2025
Novartis USD 11.52B 1.27B Jun/2025
Pfizer USD 10.88B 248M Jun/2025
PTC Therapeutics USD 163.39M 999.84M Jun/2025
Regeneron Pharmaceuticals USD 3.15B 581M Jun/2025
Roche Holding CHF 11.69B 48M Dec/2024
Sanofi EUR 7.74B 26M Jun/2025
Sarepta Therapeutics USD 457.87M 149.43M Jun/2025
Takeda JPY 722.01B 50.69B Jun/2025
Teva Pharmaceutical Industries USD 2.1B 188M Jun/2025
Ultragenyx Pharmaceutical USD 143.49M 32.86M Jun/2025
Vertex Pharmaceuticals USD 2.56B 150M Jun/2025